CytoSeek uses cell membrane augmentation technology to unlock the potential of next generation of advanced therapies.

They are a spinout company from the University of Bristol. The novel cell membrane augmentation technology enables them to add new functionalities to cell therapies including tissue-specific targeting and enhanced cell survivability.


Status current

Associated Fund UK Innovation & Science Seed Fund

Sector Medical / Biotechnology


Associated Team Members

Relevant News

Spin out secures £1.1M for ground-breaking ‘supercharged’ cell therapies to treat solid tumours

25 November 2019 A University of Bristol spin-out company has raised £1.1 million in funding…

read more

CytoSeek Wins at Launch: Great West Rising Star Award

© Giulia Spadafora / Soul Media UKI2S would like to congratulate CytoSeek on winning the…

read more

More Companies in Medical / Biotechnology